Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 8Thoracic 5Breast 5Lymphoid 3Genitourinary 3Plasma cell 2Head & Neck 2CNS 2Sarcoma 1NET 1Gynecologic 1Endocrine 1

Conditions

Lymphoma 2Sarcoma 1Prostatic Neoplasms 1Ovarian Neoplasms 1Multiple Myeloma 1Mixed Dementias 1Lymphoma, Follicular 1Lung Neoplasms 1Lewy Body Disease 1Kidney Neoplasms 1Dementia, Vascular 1Dementia 1Colorectal Neoplasms 1Cognitive Dysfunction 1Breast Neoplasms 1

Interventions

Cyclophosphamide 344Rituximab 309Vincristine 159venetoclax 156Doxorubicin 156fludarabine 153Specimen Handling 152Prednisone 150Biopsy 122Magnetic Resonance Spectroscopy 117obinutuzumab 116Lenalidomide 110Dexamethasone 106Cytarabine 100ibrutinib 96Etoposide 94fludarabine phosphate 87Methotrexate 86acalabrutinib 80zanubrutinib 73Bendamustine Hydrochloride 72pembrolizumab 63blinatumomab 63CT-P10 61Gemcitabine 52glofitamab 45Nivolumab 45Calcium Dobesilate 45prednylidene 43Mercaptopurine 43

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Referral and Consultation × Lymphoid × 1 year × Clear all
NCT05860127 2026-03-23

Cognitive Stimulation Therapy for Dementia: A Two-Armed Pragmatic Trial

University of Massachusetts, Amherst

Phase NA Completed
133 enrolled 14 charts
Lymphoid

Mixed Dementias, Dementia, Lymphoma, Follicular, Dementia, Vascular, Lewy Body Disease, Cognitive Dysfunction

NCT06063603 2025-09-18

ASCENT

Mayo Clinic

Phase NA Completed
51 enrolled 8 charts
LymphoidPlasma cell

Lymphoma, Multiple Myeloma

NCT02821793 2025-07-01

PRIORITY

Institut Bergonié

Completed
346 enrolled 9 charts
BreastGastrointestinalGenitourinaryGynecologicLymphoidSarcomaThoracic

Breast Neoplasms, Kidney Neoplasms, Lung Neoplasms, Lymphoma, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡